SCHEMBL3403591

SCHEMBL3403591

NC(=O)c1c(NC(=O)c2cc3ccccc3o2)sc2c1CCC2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 1.00
▸ RAB9A P51151 7/20 1.00
▸ MAPT P10636 4/20 1.00
▸ HPGD P15428 2/20 1.00
▸ SMN1; SMN2 Q16637 2/20 1.00
▸ MEN1 O00255 2/20 1.00
▸ CASP3 P42574 2/20 1.00
▸ KMT2A Q03164 2/20 1.00
▸ SENP7 Q9BQF6 2/20 1.00
▸ KDM4E B2RXH2 1/20 1.00
▸ ESR1 P03372 1/20 1.00
▸ TP53 P04637 1/20 1.00
▸ POLB P06746 1/20 1.00
▸ ESR2 Q92731 1/20 1.00
▸ SENP8 Q96LD8 1/20 1.00
▸ HSD17B10 Q99714 1/20 1.00
▸ SENP6 Q9GZR1 1/20 1.00
▸ ALDH1A1 P00352 1/20 0.66
▸ FLT3 P36888 7/20 0.63
▸ CCR6 P51684 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8289583 0.85 HPGD (0.74) NPC1RAB9AMAPTHPGDSMN1; SMN2
SCHEMBL3393564 0.81 NPC1 (0.68) NPC1RAB9AMAPTHPGDSMN1; SMN2
SCHEMBL8290734 0.80 HPGD (1.00) NPC1RAB9AMAPTHPGDSMN1; SMN2
SCHEMBL8289836 0.79 NPC1 (0.66) NPC1RAB9AMAPTHPGDSMN1; SMN2
SCHEMBL5453337 0.79 RAB9A (1.00) NPC1RAB9AMAPTHPGDSMN1; SMN2
SCHEMBL17916667 0.77 HPGD (0.70) NPC1RAB9AMAPTHPGDSMN1; SMN2
SCHEMBL5453296 0.77 FLT3 (1.00) NPC1RAB9AMAPTHPGDSMN1; SMN2
SCHEMBL3128198 0.77 FLT3 (1.00) NPC1RAB9AMAPTHPGDSMN1; SMN2
SCHEMBL5676825 0.76 MAPT (0.61) NPC1RAB9AMAPTHPGDSMN1; SMN2
SCHEMBL8289672 0.76 FLT3 (0.97) NPC1RAB9AMAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170189477-A1 Methods and Compositions of P27KIP1 Transcriptional Modulators NIH-DEITR 2017-07-06 — — US claimed
US-9572815-B2 Methods and compositions of p27KIP1 transcriptional modulators ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2017-02-21 — — US claimed
US-20160030445-A1 METHODS AND COMPOSITIONS OF P27KIP1 TRANSCRIPTIONAL MODULATORS ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2016-02-04 — — US claimed
EP-2254572-A2 COMPOUNDS THAT ENHANCE ATOH-1 EXPRESSION Massachusetts Eye & Ear Infirmary (US) 2010-12-01 — — EP claimed
US-20090232780-A1 COMPOUNDS THAT ENHANCE ATOH1 EXPRESSION MASSACHUSETTS EYE & EAR INFIRMARY (US) 2009-09-17 — — US claimed
WO-2009100438-A2 COMPOUNDS THAT ENHANCE ATOH-1 EXPRESSION MASSACHUSETTS EYE & EAR INFIRMARY (US) 2009-08-13 — — WO claimed
US-20250099539-A1 METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS AND/OR SUPPORTING CELLS MASSACHUSETTS EYE AND EAR INFIRMARY 2025-03-27 — — US disclosed
US-12239651-B2 Treatment of hearing loss MASSACHUSETTS EYE AND EAR INFIRMARY (US) 2025-03-04 — — US disclosed
US-12156899-B2 Methods and compositions for regenerating hair cells and/or supporting cells MASSACHUSETTS EYE AND EAR INFIRMARY (US) 2024-12-03 — — US disclosed
US-20240299432-A1 TREATMENT OF HEARING LOSS MASSACHUSETTS EYE AND EAR INFIRMARY 2024-09-12 — — US disclosed
US-12043653-B2 Efficient delivery of therapeutic molecules to cells of the inner ear MASSACHUSETTS EYE AND EAR INFIRMARY (US) 2024-07-23 — — US disclosed
US-11963968-B2 Treatment of hearing loss MASSACHUSETTS EYE AND EAR INFIRMARY (US) 2024-04-23 — — US disclosed
US-20240100079-A1 METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS IN THE INNER EAR OF ADULT MAMMALS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-03-28 — — US disclosed
US-20120328580-A1 COMPOUNDS THAT ENHANCE ATOH1 EXPRESSION MASSACHUSETTS EYE & EAR INFIRMARY 2012-12-27 — — US disclosed
US-8188131-B2 Compounds that enhance Atoh1 expression MASSACHUSETTS EYE & EAR INFIRMARY (US) 2012-05-29 — — US disclosed
US-8188131-B2 Compounds that enhance Atoh1 expression MASSACHUSETTS EYE & EAR INFIRMARY (US) 2012-05-29 — — US disclosed
US-8188131-B2 Compounds that enhance Atoh1 expression MASSACHUSETTS EYE & EAR INFIRMARY (US) 2012-05-29 — — US disclosed
US-20090232780-A1 COMPOUNDS THAT ENHANCE ATOH1 EXPRESSION MASSACHUSETTS EYE & EAR INFIRMARY (US) 2009-09-17 — — US disclosed
US-20090232780-A1 COMPOUNDS THAT ENHANCE ATOH1 EXPRESSION MASSACHUSETTS EYE & EAR INFIRMARY (US) 2009-09-17 — — US disclosed
US-20090232780-A1 COMPOUNDS THAT ENHANCE ATOH1 EXPRESSION MASSACHUSETTS EYE & EAR INFIRMARY (US) 2009-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240299432-A1 TREATMENT OF HEARING LOSS HES1, NOTCH1, NOTCH4 NPC1 1607/4885RAB9A 1434/4885MAPT 3170/4885
US-12043653-B2 Efficient delivery of therapeutic molecules to cells of the inner ear HES1, NOTCH1, NOTCH2 NPC1 1630/4885RAB9A 2455/4885MAPT 3320/4885
US-20170189477-A1 Methods and Compositions of P27KIP1 Transcriptional Modulators WNT1, CTNNB1, CTNNBL1 NPC1 1011/4885RAB9A 4314/4885MAPT 2567/4885
US-12156899-B2 Methods and compositions for regenerating hair cells and/or supporting cells HES1, NOTCH1, NOTCH4 NPC1 1656/4885RAB9A 3020/4885MAPT 3747/4885
US-20250099539-A1 METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS AND/OR SUPPORTING CELLS HES1, NOTCH1, NOTCH4 NPC1 1656/4885RAB9A 3020/4885MAPT 3747/4885
US-20160030445-A1 METHODS AND COMPOSITIONS OF P27KIP1 TRANSCRIPTIONAL MODULATORS WNT1, CTNNB1, CTNNBL1 NPC1 966/4885RAB9A 4168/4885MAPT 2501/4885
US-20090232780-A1 COMPOUNDS THAT ENHANCE ATOH1 EXPRESSION DACH1, EZH1, CREBBP NPC1 1018/4885RAB9A 3293/4885MAPT 3010/4885
US-20120328580-A1 COMPOUNDS THAT ENHANCE ATOH1 EXPRESSION DACH1, EZH1, CREBBP NPC1 1018/4885RAB9A 3293/4885MAPT 3010/4885
US-12239651-B2 Treatment of hearing loss HES1, NOTCH1, NOTCH4 NPC1 1607/4885RAB9A 1434/4885MAPT 3170/4885
US-11963968-B2 Treatment of hearing loss HES1, NOTCH1, NOTCH4 NPC1 1607/4885RAB9A 1434/4885MAPT 3170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback